Effectiveness of Peripheral Intravenous Line Securement With Splint in Neonates

Effectiveness of Peripheral Intravenous Line Securement With Splint in Neonates Admitted to the Neonatal Intensive Care Unit.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07589010

Enrollment

192

Registered

2026-05-15

Start date

2025-10-01

Completion date

2026-03-31

Last updated

2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Intravenous Line

Brief summary

Splints are often used in neonatal intensive care units (NICUs) to immobilize the limb and stabilize the catheter, theoretically reducing complications by minimizing movement at the catheter site. Unfortunately, not much local data exist on the effectiveness of splints for peripheral intravenous line securement (PIVC). This study aimed to compare the dwell time of PIVCs with and without splints in neonates admitted to the NICU.

Detailed description

The expected outcomes, which included optimized PIVC management protocols that could lower the frequency of catheter replacements, thereby reducing neonatal distress and the risk of infection. Establishing clear best practices may improve overall care quality, enhance workflow efficiency for NICU staff, and ultimately lead to better health outcomes. The findings could support the development of standardized guidelines for PIVC securement, with implications not only for local but also for global neonatal care settings.

Interventions

PROCEDURESplint

Neonates were supported with a splint for PIVC securement.

PROCEDURENeonates were not supported with a splint

Neonates were not supported with a splint for PIVC securement.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

1 Days to 28 Days

Healthy volunteers

Inclusion criteria

* Neonates * Any gender * Admitted to the NICU and required PIVC insertion

Exclusion criteria

* Skin conditions like fragile skin syndromes, dermatitis, or local infections that may worsen with splint and adhesive use * Congenital limb deformities like clubfoot, polydactyly, joint contractures that impede proper splint application * Severe limb edema

Design outcomes

Primary

Measure	Time frame	Description
Dwell time	One week	The dwell time of PIVCs with and without splints was compared, calculated from PIVC insertion to the completion of the therapy.

Countries

Pakistan

Contacts

PRINCIPAL_INVESTIGATORZainab Khalid

Dr. Ruth KM Pfau Civil Hospital/Karachi, Dow University of Health Sciences, Karachi

STUDY_DIRECTORMuhammad Rafique, FCPS

Dr. Ruth KM Pfau Civil Hospital, Karachi/Dow University of Health Sciences, Karachi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026